Review
doi: 10.1007/978-3-0348-7081-8_7.
Lysostaphin: model for a specific enzymatic approach to infectious disease
- PMID: 4265118
- DOI: 10.1007/978-3-0348-7081-8_7
Item in Clipboard
Review
Lysostaphin: model for a specific enzymatic approach to infectious disease
Prog Drug Res.
1972.
No abstract available
Similar articles
-
Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.Antimicrob Agents Chemother. 2002 Jun;46(6):2017-20. doi: 10.1128/AAC.46.6.2017-2020.2002. Antimicrob Agents Chemother. 2002. PMID: 12019130 Free PMC article.
-
Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies.Yale J Biol Med. 1967 Feb;39(4):230-44. Yale J Biol Med. 1967. PMID: 4961995 Free PMC article. No abstract available.
-
Lysostaphin.J Infect Dis. 1969 Jan;119(1):101-2. doi: 10.1093/infdis/119.1.101. J Infect Dis. 1969. PMID: 5191239 No abstract available.
-
[Clinical strains of staphylococci resistant to semisynthetic penicillins].Antibiotiki. 1967 Oct;12(10):950-8. Antibiotiki. 1967. PMID: 4871268 Review. Russian. No abstract available.
-
Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology.Ann N Y Acad Sci. 1974 Jul 31;236(0):413-34. doi: 10.1111/j.1749-6632.1974.tb41507.x. Ann N Y Acad Sci. 1974. PMID: 4608264 Review. No abstract available.
Cited by
-
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.Antimicrob Agents Chemother. 2003 Nov;47(11):3407-14. doi: 10.1128/AAC.47.11.3407-3414.2003. Antimicrob Agents Chemother. 2003. PMID: 14576095 Free PMC article.
-
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Antimicrob Agents Chemother. 1998 Jun;42(6):1355-60. doi: 10.1128/AAC.42.6.1355. Antimicrob Agents Chemother. 1998. PMID: 9624475 Free PMC article.
-
Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.BMC Res Notes. 2012 Jun 8;5:280. doi: 10.1186/1756-0500-5-280. BMC Res Notes. 2012. PMID: 22682527 Free PMC article.
-
Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.Antimicrob Agents Chemother. 2002 Jun;46(6):2017-20. doi: 10.1128/AAC.46.6.2017-2020.2002. Antimicrob Agents Chemother. 2002. PMID: 12019130 Free PMC article.
-
Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia.Biomed Res Int. 2014;2014:602185. doi: 10.1155/2014/602185. Epub 2014 Jul 16. Biomed Res Int. 2014. PMID: 25136599 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources